文献速递前列腺增生与排尿功能障碍

球部尿道成形术后狭窄复发的内镜治疗多中心结局

Multi-Institutional Outcomes of Endoscopic Management of Stricture Recurrence after Bulbar Urethroplasty.
PubMed 文献 · J Urol · 2018-05-03

本研究回顾性分析了5名TURNS网络外科医生收治的球部尿道成形术后狭窄复发患者,初始内镜治疗包括尿道扩张或直视下尿道内切开术。结果显示总体成功率为42%;尿道扩张成功率显著低于直视下尿道内切开术(10% vs 49%,p<0.001),且直视下尿道内切开术在替代成形术后复发中比在切除吻合术后更有效(53% vs 13%,p=0.005)。

要点

  • 球部尿道成形术后复发初始内镜治疗总体成功率为42%。
  • 直视下尿道内切开术成功率显著高于尿道扩张(49% vs 10%)。
  • 直视下尿道内切开术在替代成形术后复发中更有效(53% vs 13%)。

核心结论

  • 直视下尿道内切开术治疗球部尿道成形术后狭窄复发优于尿道扩张。
  • 直视下尿道内切开术在替代成形术后复发中比切除吻合术后更成功。

研究设计与样本

  • 回顾性多中心研究,纳入5名TURNS网络外科医生的球部尿道成形术后复发患者。
  • 复发定义为17Fr膀胱镜无法通过重建区域。
  • 共53名男性接受初始内镜治疗(尿道扩张或直视下尿道内切开术)。

主要发现

  • 尿道成形术后狭窄复发中位时间为5个月。
  • 中位随访5个月,总体成功率为42%。
  • 尿道扩张成功率为10%(1/10),直视下尿道内切开术为49%(21/43),p<0.001。
  • 尿道扩张失败风险比为3.15(p=0.03)。
  • 直视下尿道内切开术在替代成形术后成功率为53%,在切除吻合术后为13%(p=0.005)。

临床怎么用

  • 球部尿道成形术后狭窄复发可优先考虑直视下尿道内切开术而非尿道扩张。
  • 需根据原成形术式(切除吻合 vs 替代成形)预判内镜治疗成功率。

局限性

  • 回顾性研究设计。
  • 样本量较小(53例)。
  • 中位随访时间仅5个月。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Approximately 10% to 20% of patients will have a recurrence after urethroplasty. Initial management of these recurrences is often by urethral dilation or direct vision internal urethrotomy. In the current study we describe the outcomes of endoscopic management of stricture recurrence after bulbar urethroplasty. MATERIALS AND METHODS: We retrospectively reviewed bulbar urethroplasty data from 5 surgeons in the TURNS (Trauma and Urologic Reconstruction Network of Surgeons). Men who underwent urethral dilation or direct vision internal urethrotomy for urethroplasty recurrence were identified. Recurrence was defined as the inability to pass a 17Fr cystoscope through the area of reconstruction. The primary outcome was the success rate of recurrence management. Comparisons were made between urethral dilation and direct vision internal urethrotomy, and then between endoscopic management of recurrences after excision and primary anastomosis urethroplasty vs substitutional repairs using time to event statistics. RESULTS: In 53 men recurrence was initially managed endoscopically. Median time to urethral stricture recurrence after urethroplasty was 5 months. At a median followup of 5 months the overall success rate was 42%. Success after urethral dilation was significantly less than after direct vision internal urethrotomy (1 of 10 patients or 10% vs 21 of 43 or 49%, p <0.001) with a failure HR of 3.15 (p = 0.03). Direct vision internal urethrotomy was more effective after substitutional failure than after excision and primary anastomosis urethroplasty (53% vs 13%, p = 0.005). CONCLUSIONS: Direct vision internal urethrotomy was more successful than urethral dilation in the management of stricture recurrence after bulbar urethroplasty. Direct vision internal urethrotomy was more successful in patients with recurrence after substitution urethroplasty compared to after excision and primary anastomosis urethroplasty. Perhaps this indicates a different mechanism of recurrence for excision and primary anastomosis urethroplasty (ischemic) vs substitution urethroplasty (nonischemic).

来源:J Urol,查看原文。版权归原作者所有。

引用

  1. Sukumar S, Elliott SP, Myers JB, et al. Multi-Institutional Outcomes of Endoscopic Management of Stricture Recurrence after Bulbar Urethroplasty. J Urol. 2018. PMID: 29730205. doi:10.1016/j.juro.2018.04.081

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。